Patients with higher estimated proportions of CD4+ T cells, CD8+ T cells and B cells had lower all-cause and CRC-specific mortality, and patients with a higher proportion of neutrophils had higher all-cause and CRC-specific mortality. This evidence concerns the gene CD8A and colorectal carcinoma.